Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Organogenesis Holdings (ORGO) Assets Average (2016 - 2025)

Historic Assets Average for Organogenesis Holdings (ORGO) over the last 10 years, with Q3 2025 value amounting to $485.5 million.

  • Organogenesis Holdings' Assets Average rose 916.24% to $485.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $485.5 million, marking a year-over-year increase of 916.24%. This contributed to the annual value of $479.0 million for FY2024, which is 533.62% up from last year.
  • According to the latest figures from Q3 2025, Organogenesis Holdings' Assets Average is $485.5 million, which was up 916.24% from $464.3 million recorded in Q2 2025.
  • In the past 5 years, Organogenesis Holdings' Assets Average registered a high of $485.5 million during Q3 2025, and its lowest value of $304.7 million during Q1 2021.
  • Moreover, its 5-year median value for Assets Average was $450.8 million (2024), whereas its average is $435.8 million.
  • Its Assets Average has fluctuated over the past 5 years, first soared by 5882.82% in 2021, then tumbled by 257.42% in 2024.
  • Quarter analysis of 5 years shows Organogenesis Holdings' Assets Average stood at $406.8 million in 2021, then rose by 11.42% to $453.3 million in 2022, then rose by 1.77% to $461.3 million in 2023, then grew by 2.33% to $472.1 million in 2024, then grew by 2.84% to $485.5 million in 2025.
  • Its Assets Average was $485.5 million in Q3 2025, compared to $464.3 million in Q2 2025 and $482.6 million in Q1 2025.